PomDoctor Ltd. (POM) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Sep 30Oct 5Oct 8Oct 13Oct 16Oct 21Oct 26Oct 29

Key dataOct 29, 2026

Open$1.74

From 52W high−98.18%

Volume1.62M

Market cap$5.53M

P/E (TTM)—

P/S (TTM)0.1x

Div yield—

Key dataOct 29, 2026

Open

$1.74

From 52W high

−98.18%

Volume

1.62M

Market cap

$5.53M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−0.4x

P/E (TTM)

—

RSI (14)

50.2

MomentumView details →

1D Return

+10.56%

YTD Return

−63.47%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−0.4x

EV/Sales

0.3x

P/S (TTM)

0.1x

P/B (TTM)

−0.5x

ProfitabilityView details →

Gross Margin

11.68%

Net Margin

−83.71%

EBITDA Margin

−74.05%

ROE (TTM)

416.40%

ROA (TTM)

−2573.37%

Asset Turnover

7.90x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

+17.71%

EPS CAGR 3Y

+3.35%

EBITDA YoY

—

MomentumView details →

1D Return

+10.56%

YTD Return

−63.47%

1Y Return

−98.02%

RSI (14)

50.2

vs 50D SMA

+21.61%

vs 200D SMA

−37.43%

Capital & dividendView details →

Debt/Equity

−0.96x

Current Ratio

0.35x

Quick Ratio

0.32x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

345.02M

Net Income (TTM)

−288.80M

Op. CF (TTM)

−126.98M

Latest newsMore news →

Pomdoctor Limited provided an update on the continued development and commercialization of its AI-enabled chronic disease management ecosystem, including optimization of its proprietary AI chronic disease management system, expanded real-world data applications, and integrated in-hospital and out-of-hospital chronic disease management pilots.30d ago

Similar companies

Bio Green Med Solution, Inc.BGMS Cellyan Biotechnology Co., LtdHKPD Eocene Ltd.EOCN Hoth Therapeutics, Inc.RKTO Plus Therapeutics, Inc.CNSY Bio Green Med Solution, Inc.BGMSP Find similar companies →

Latest newsMore news →

Pomdoctor Limited provided an update on the continued development and commercialization of its AI-enabled chronic disease management ecosystem, including optimization of its proprietary AI chronic disease management system, expanded real-world data applications, and integrated in-hospital and out-of-hospital chronic disease management pilots.30d ago